These are the stocks posting the largest moves in premarket trading.
for a phase three trial of a lung cancer treatment.
While the drug compared well to a competitor on one endpoint, the data for overall survival was "not mature" and pointed toward to the results being not statistically significant, AstraZeneca said in a press release. The trial will continue, according to the company.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Tesla shares rally on delivery numbers, AstraZeneca stock slumps on drug trial, and other stocks on the moveTesla and AstraZeneca stock head in opposite directions.
続きを読む »
AstraZeneca shares slump after Phase 3 lung cancer drug studyAstraZeneca’s shares slumped 6% in premarket trade. The U.K. drugmaker said its datopotamab deruxtecan treatment showed positive results in patients with...
続きを読む »
Wall Street analysts reveal their top ideas for the second half, including this red-hot solar nameWall Street analysts named their top second half stocks this week.
続きを読む »
Ontario driver charged $6,845 following Tesla test-drive collisionICYMI: Ontario driver charged $6,845 following Tesla test-drive collision — via drivingdotca autonews
続きを読む »
Study Explains Why Everyone Is Adopting Tesla's Supercharging Network | CarscoopsA new customer satisfaction study by J.D. Power sheds light into why more and more companies are adopting Tesla's charging standard car auto cars
続きを読む »
Recession will take shine off stocks' AI-fueled rally in H2: HSBCUS stocks face a painful rest of 2023 with a recession set to take the shine off the AI-fueled rally, HSBC says
続きを読む »